In a new study, researchers have identified high-CBD extract (CBD-X) as a potential game-changer for asthma treatment, especially for patients who find little relief from conventional inhaled corticosteroids.
Published in the Journal of Pharmaceuticals, the study reveals how CBD-X could disrupt key inflammatory pathways driving asthma’s chronic symptoms, potentially offering fresh hope to millions worldwide suffering from this relentless respiratory condition.
Asthma impacts over 10% of the global population and is characterized by persistent airway inflammation, mucus overproduction, and bronchial hyperresponsiveness. While asthma treatments have advanced, a significant number of individuals—particularly those with “type 2-low” asthma—remain unresponsive to standard therapies, creating an urgent need for alternative solutions.
Continue reading